A clinical evidence review for hormone practitioners on cardiovascular safety — covering TRT and the TRAVERSE trial, hematocrit management, HRT timing hypothesis, lipid effects, and patient risk stratification.
A guide for hormone practitioners on continuing medical education — covering A4M certification, IFM functional medicine, ABOM, Endocrine Society resources, and mentorship programs.
A guide for hormone practitioners on integrating functional lab testing — covering DUTCH testing, organic acids, genetic testing, GI mapping, and advanced cardiovascular markers.
A clinical guide for practitioners on longevity medicine — covering biological age testing, NAD+ optimization, senolytics, VO2max, and longevity pharmacology including metformin and rapamycin.
A practitioner’s guide to compounding pharmacy partnerships — covering 503A vs. 503B regulations, quality indicators, common formulations, prescription writing, and managing pharmacy transitions.
A clinical guide for hormone practitioners on sexual health — covering ED evaluation and treatment, PDE5 inhibitors, low libido in women, genitourinary syndrome of menopause, and psychosexual factors.
A guide for practitioners on informed consent in hormone therapy — covering legal requirements, TRT-specific consent, off-label use documentation, compounded medication consent, and best practices.
A guide for practitioners opening telehealth weight loss and metabolic health clinics — covering GLP-1 prescribing, patient intake, clinical scope, ABOM certification, and long-term care protocols.
A clinical and patient communication guide for practitioners on bioidentical hormone replacement therapy — covering FDA-approved options, compounded BHRT, safety evidence, and informed consent.
A growth strategy guide for hormone practitioners on building referral networks — covering ideal referral partners, outreach approach, seamless referral experiences, and digital collaboration.
